The transmembrane sensor protein VirA activates VirG in response to high levels of acetosyringone (AS). In order to respond to low levels of AS, VirA requires the periplasmic sugar-binding protein ChvE and monosaccharides released from plant wound sites. To better understand how VirA senses these inducers, the C58 virA gene was randomly mutagenized, and 14 mutants defective in vir gene induction and containing mutations which mapped to the input domain of VirA were isolated. Six mutants had single missense mutations in three widely separated areas of the periplasmic domain. Eight mutants had mutations in or near an amphipathic helix, TM1, or TM2. Four of the mutations in the periplasmic domain, when introduced into the corresponding A6 virA sequence, caused a specific defect in the vir gene response to glucose. This suggests that most of the periplasmic domain is required for the interaction with, or response to, ChvE. Three of the mutations from outside the periplasmic domain, one from each transmembrane domain and one from the amphipathic helix, were made in A6 virA. These mutants were defective in the vir gene response to AS. These mutations did not affect the stability or topology of VirA or prevent dimerization; therefore, they may interfere with detection of AS or transmission of the signals to the kinase domain. Characterization of C58 chvE mutants revealed that, unlike A6 VirA, C58 VirA requires ChvE for activation of the vir genes.Agrobacterium tumefaciens causes tumors on plants by transferring a segment of its DNA, encoding genes for phytohormone and opine synthesis, from the tumor-inducing plasmid (pTi) into the plant cells, where it is integrated into the genome and expressed (for recent reviews, see references 16, 17, and 52). Ti plasmids are classified according to the opines which are synthesized in the tumors they induce. pTiC58 and pTiA6 are examples of nopaline-type and octopine-type Ti plasmids, respectively. The transfer of the DNA requires a set of virulence (vir) genes on pTi. These genes are expressed following activation of the VirA-VirG two-component regulatory system.